Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026
GlobeNewswire, Inc.
BOSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today announced that the company will present new interim data from its Phase...
PyroGenesis Confirms Completion of Installation of 4.5 MW Plasma Torch System at U.S. Defense and Aeronautics Research Facility
GlobeNewswire, Inc.
MONTREAL, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to...
GATC Health's Derisq Named One of The Scientist's 2026 Top Innovations
GlobeNewswire, Inc.
GATC’s Derisq™, the definitive AI report for predictive risk intelligence, named a Top Emerging Startup Technology by independent panel of life sciences experts at the esteemed publication.
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
GlobeNewswire, Inc.
PHILADELPHIA, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided, biotech/life sciences company focused on advancing novel and potentially disruptive therapeutic assets, today...
Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality
GlobeNewswire, Inc.
CLEARWATER, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today...
Fieldguide Reaches Agreement with CPA Canada to Embed Trusted Canadian Engagement Forms within Industry-Leading Agentic AI
GlobeNewswire, Inc.
SAN FRANCISCO and TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Fieldguide, the leading transformation partner for agentic audit and advisory, today announced a new agreement with CPA Canada to embed the organization's trusted Professional...
Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout
GlobeNewswire, Inc.
Rapid completion of Part A enrollment underscores strong operational execution and investigator engagement in relapsed or refractory acute myeloid leukemia Full Part A population expected to provide important efficacy insights across subjects who...
Nxera Announces Successful Resolution of miniG Patent Infringement Action
GlobeNewswire, Inc.
Tokyo, Japan and Cambridge and London, UK, 30 September 2026 – Nxera Pharma Co., Ltd. (“Nxera Pharma” or “the Company”; TSE 4565) announces that its wholly owned subsidiary Nxera Pharma UK Limited (“Nxera”) has entered into a settlement agreement...
Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities
GlobeNewswire, Inc.
Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities The acquisition adds advanced yeast-breeding expertise with a proven track record in bioethanol and broader potential across industries.
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
GlobeNewswire, Inc.
OKYO demonstrates continued commitment to optometry and ophthalmology LONDON and NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for...
BOS Robotics Division Receives $380,000 Follow-On Order from a Leading Israeli Defense Customer
GlobeNewswire, Inc.
RISHON LE ZION, Israel, Oct. 01, 2026 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (Nasdaq: BOSC), an integrator of supply chain technologies for the aerospace, defense, industrial and retail sectors, today...
Ocugen to Participate in Upcoming October Investor and Industry Conferences
GlobeNewswire, Inc.
MALVERN, Pa., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that members of its executive leadership...
Scintil Photonics Appoints Alexandru Romanescu as Vice President of Process Engineering
GlobeNewswire, Inc.
GRENOBLE, France, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Scintil Photonics, the global technology leader in Heterogeneous Integrated Photonics for next-generation DWDM AI infrastructure, today announced that Alexandru Romanescu has joined the company...
NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
GlobeNewswire, Inc.
- SPINOZA is studying obicetrapib in adults with biomarker evidence suggestive of preclinical Alzheimer’s disease who do not have noticeable memory or functional symptoms- - The study will evaluate changes in blood-based biomarkers associated with...
Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer
GlobeNewswire, Inc.
Incidence and prevalence of OPSCC continue to rise in the U.S. largely driven by HPV infection OPSCC is estimated to represent 1 in 2 head and neck cancer patients in the 2L+ setting in the U.S. with approximately 14,000 patients eligible for...
argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline
GlobeNewswire, Inc.
New data show deepening improvement in ocular MG and sustained one-year efficacy in anti-AChR antibody-negative MG – broadening VYVGART's potential to treat all MG patients Real-world evidence from more than 1,100 U.S. MG patients indicates the...
Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD
GlobeNewswire, Inc.
Initiation of registrational Phase 3 study of VOQUEZNA® (vonoprazan) for as-needed (PRN) use in Non-Erosive Reflux Disease (NERD) builds on previously reported positive Phase 2 data Topline results expected in the first quarter of 2028...
MCPU Polymer Engineering Introduces 'Biocongruent Chemistry,' a New Framework for Sustainable Polymers, at Polycon 2026
EIN Presswire
Soy- and lignin-based additives replace halogenated flame retardant TCPP in polyurethane insulation foam and improve end-of-life biodegradation.
WSP to acquire GCM Corpo, expanding its energy platform in Canada
GlobeNewswire, Inc.
MONTREAL, Oct. 01, 2026 (GLOBE NEWSWIRE) -- WSP Global Inc. (TSX: WSP) ("WSP"), one of the world’s leading engineering, science and infrastructure solutions firms, has entered into an agreement to acquire GCM Corpo Inc. ("GCM Corpo"), a Canadian...
Pharmazz Completes Enrollment in 160-Patient Phase 4 Trial of Sovateltide in Acute Ischemic Stroke
GlobeNewswire, Inc.
Enrollment completed in the double-blind, placebo-controlled Phase 4 study (NCT05955326) of sovateltide (Tycamzzi®), with final study data expected in Q1 2027 Five sovateltide abstracts accepted at World Stroke Congress, October 21-23, 2026,...
Sign up for:
Technology News Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.